SELE and COVID-19: [34] Overall, the study by Oliva et al. suggests that COVID-19 ARDS is characterized by an early pulmonary endothelial injury and that E-selectin might be a marker of severe disease course and/or clinical deterioration in COVID-19 patients but does not predict survival [34].